Krebs Biochemicals & Industries Ltd has submitted to BSE a copy of Recommendation of Committee of Independent Directors (IDC) on the Open Offer to the Equity Shareholders of Krebs Biochemicals and Industries Ltd ('Target Company/TC') by Ipca Laboratories Ltd ('the Acquirer') for acquisition of 35,73,515 Equity Shares under Regulations 3(1) and 4 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (' SEBI SAST Regulations').
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
